Massimo Pinzani

Ernst & Young LLP engages in the provision of accounting, assurance, tax, transaction, and advisory services. It specializes in the actuarial, analytics and big data, cyber security, accounting compliance and reporting, center for board matters, international financial reporting standards, country tax advisory, global trade, tax accounting, and climate change and sustainability. The company was founded in 1989 and is headquartered in New York, NY.

KuDOS Pharmaceuticals Ltd. discovers and develops pharmaceutical products. Its products are used to treat DNA damage sensing, signaling, viral disease, ischaemia, and repair to address unmet medical needs in cancer treatment. The company was founded by Stephen Jackson on December 12, 1997 and is headquartered in Cambridge, UK.

Oxsight Ltd. provides research and experimental development on natural sciences and engineering services. The firm specializes in augmented reality, image interpretation, smart glasses, customer care, agile development and wearable technology. The company was founded by Stephen Lloyd Frederick hicks and Philip Torr and is headquartered in Oxford, the United Kingdom.

The American Society of Clinical Oncology is a non-profit organization founded in 1964 with the overarching goals of improving cancer care and prevention. More than 27,000 oncology practitioners belong to ASCO, representing all oncology disciplines and subspecialties. Members include physicians and health-care professionals in all levels of the practice of oncology. American Society of Clinical Oncology is the world’s leading professional organization representing physicians who treat people with cancer. ASCO’s members set the standard for patient care worldwide and lead the way in carrying out clinical research aimed at improving the prevention, diagnosis, and treatment of cancer. ASCO's efforts are also directed toward advocating for policies that provide access to high-quality care for all patients with cancer and at supporting the increased funding for clinical and translational research.

American Association for Cancer Research prints and publishes scientific journals including clinical cancer research, molecular cancer therapeutics, molecular cancer research, cancer epidemiology, and biomarkers and prevention. The company was founded on May 7, 1907 and is headquartered in Philadelphia, PA.

The General Medical Council provides business support services. The non-profit company is based in London, UK. The CEO of the British company is Charlie Massey.

Ichnos Sciences, Inc. operates as a biotechnology company. It provides curative therapies that extend human life. The company was founded in 2019 and is headquartered in Paramus, NJ.

Kymab Ltd. discovers and develops human monoclonal antibody drugs. It is using mouse embryonic stem cell technology to develop its Kymouse platform that focuses on encompassing the diversity of the B lymphocyte component of the human immune system, and has the potential for expansion of diversity beyond the normal human immune response. Kymab was founded by Allan Bradley in 2009 and is headquartered in Cambridge, the United Kingdom.

Mazza Innovation Ltd. provides plant extraction technology. Its products include PhytoClean which yields clean ingredients in an earth-friendly manner from plants. The company was founded by Giuseppe Mazza, Carl Pronyk, and Eduardo Cacace in August 2011 and is headquartered Delta, Canada.

Deontics Ltd. provides clinical software to process scientific information. It commercializes clinical pathways and clinical decision support systems developed at cancer research UK, oxford university and university college london. The company was founded by John Fox, Guy Wood-Gush and Ioannis Chronakis and is headquartered in London, the United Kingdom.

MerLion Pharmaceuticals Pte Ltd. provides drug discovery and development services. It focuses on developing its lead antibacterial candidate, finafloxacin, through early and mid-stage clinical trials. The company was founded in 2002 and is headquartered in Singapore.

Intelligent Ultrasound Ltd. provides ultrasound software solution. Its IQA Audit offers users a comprehensive, independently conducted audit of ultrasound images stored as part of the patient record. The firm's IQA Metrics provides managers and users with metrics, derived from data recorded from the ultrasound equipment during use, to support decision-making. The company was founded by Aris Papageorghiou, Alison Noble and Andrew Hill and is headquartered in Abingdon, the United Kingdom.

First Light Fusion Ltd. manages a research intensive company in energy and process engineering. It engages in developing technology for inertial confinement fusion, using a radically different approach. The firm discovers implosion processes for electricity generation. The company was founded by Yiannis Ventikos and Nicholas Hawker in 2011 and is headquartered in Begbroke, the United Kingdom.

Technikos LLP (Technikos) is a venture capital firm founded in 2006. The firm is headquartered in London.

BlueCrest Capital Management Ltd. (BlueCrest) is a single-family office headquartered in St. Helier, UK. They are a subsidiary of WHR Investments Ltd., ultimately owned by BC Cayman Charitable Trust in Cayman Islands. The firm was previously a hedge fund management firm and in 2015, Michael Platt decided to turn BlueCrest into a firm that only managed his own money and money that belongs to BlueCrest partners and employees.

BC Capital Management Services Ltd. operates as an alternative investment manager. The company was founded in 2000 and is headquartered in London, the United Kingdom.

BlueCrest Capital Management (UK) LLP (BCM-UK) is an independent, Great Britain-based alternative asset management firm headquartered in London. The firm was founded in 2009 by Michael Platt and Bill Reeves to manage their flagship fund, BlueCrest Capital International. In 2015, they transitioned to a Private Investment Partnership and returned client capital. BCM-UK currently manages assets solely on behalf of their partners and employees.

Dyson, Inc. operates as a technology company. It designs and manufactures household appliances such as vacuum cleaners, hand dryers, bladeless fans, heaters and hair dryers. The company was founded by James Dyson and is headquartered in Chicago, IL.

Ariceum Therapeutics GmbH is a German clinical stage radiopharmaceutical company that focuses on the diagnosis and precision treatment of certain neuroendocrine and other aggressive, hard-to-treat cancers. Ariceum Therapeutics is based in Berlin, DE, and has subsidiaries in various locations worldwide. The company's lead targeted systemic radiopharmaceutical product, -satoreotide tetraxetan ("satoreotide"), is an antagonist of the somatostatin type 2 (sstr2) receptor, which is overexpressed in neuroendocrine tumors (NETs) and some aggressive cancers such as small cell lung cancer (SCLC) and Merkel cell carcinoma. Ariceum is also developing a radiolabeled PARP-inhibitor (ATT-001), which is slated to enter the clinic in early 2024. The company was founded in 2021, and Manfred Rüdiger has been the CEO of the company since 2021.